ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Chun Te Chen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5109529764. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper

Papers 1

A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. Co-author PMID 28401019 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ping Chang · 1 shared paper, 2017 · strength 0.06
- Paper A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. PMID 28401019 ↗
Haoqiang Ying · 1 shared paper, 2017 · strength 0.06
- Paper A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. PMID 28401019 ↗
Ronald Anthony Depinho · 1 shared paper, 2017 · strength 0.06
- Paper A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. PMID 28401019 ↗
Mien‐Chie Hung · 1 shared paper, 2017 · strength 0.06
- Paper A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. PMID 28401019 ↗
Donghui Li · 1 shared paper, 2017 · strength 0.06
- Paper A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. PMID 28401019 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.